Pathway of binding of the intrinsically disordered mitochondrial inhibitor protein to F1-ATPase
See allHide authors and affiliations
Contributed by John E. Walker, June 23, 2014 (sent for review June 12, 2014)

Significance
ATP, the fuel of biology, is produced by a molecular machine with a rotary action inside the mitochondria of living cells. Rotation is driven by a proton motive force (a voltage) across the inner membranes of the organelle generated from the controlled oxidation of sugars and fats in food-stuffs. If the cell were to encounter anoxic conditions, the rotary machine would use the energy stored in ATP and reverse its rotation. To prevent this wastage, reversal, but not forward rotation, is prevented by an intrinsically unfolded inhibitor protein, IF1, which inserts itself in the machine and stops reverse rotation. The article describes how this intrinsically disordered protein gains α-helical structure during the process of insertion into the machine.
Abstract
The hydrolysis of ATP by the ATP synthase in mitochondria is inhibited by a protein called IF1. Bovine IF1 has 84 amino acids, and its N-terminal inhibitory region is intrinsically disordered. In a known structure of bovine F1-ATPase inhibited with residues 1–60 of IF1, the inhibitory region from residues 1–50 is mainly α-helical and buried deeply at the αDPβDP-catalytic interface, where it forms extensive interactions with five of the nine subunits of F1-ATPase but mainly with the βDP-subunit. As described here, on the basis of two structures of inhibited complexes formed in the presence of large molar excesses of residues 1–60 of IF1 and of a version of IF1 with the mutation K39A, it appears that the intrinsically disordered inhibitory region interacts first with the αEβE-catalytic interface, the most open of the three catalytic interfaces, where the available interactions with the enzyme allow it to form an α-helix from residues 31–49. Then, in response to the hydrolysis of an ATP molecule and the associated partial closure of the interface to the αTPβTP state, the extent of the folded α-helical region of IF1 increases to residues 23–50 as more interactions with the enzyme become possible. Finally, in response to the hydrolysis of a second ATP molecule and a concomitant 120° rotation of the γ-subunit, the interface closes further to the αDPβDP-state, allowing more interactions to form between the enzyme and IF1. The structure of IF1 now extends to its maximally folded state found in the previously observed inhibited complex.
A small basic protein, known as IF1, found in the matrix of mitochondria, is a potent inhibitor of hydrolysis of ATP by mitochondrial F1-ATPase (1). This protein also inhibits the ATP hydrolytic activity of the intact mitochondrial F1Fo-ATPase, but not its ability to synthesize ATP in the presence of a proton motive force (2). Hence, IF1 is a unidirectional inhibitor of ATP hydrolysis only.
Bovine IF1 is 84 amino acids long (3), and the active form is a homodimer held together by an antiparallel coiled-coil of α-helices from residues 49–81. Its N-terminal region from residues 1–45 provides the inhibitory part of the protein, and the dimeric inhibitor binds to two F1-ATPase complexes simultaneously (4). A monomeric form of IF1 comprising residues 1–60 is also an effective inhibitor, and in a structure (known as F1-I1-60His) of bovine F1-ATPase inhibited by this monomeric form, the inhibitor is buried deeply in a complex binding site in which the inhibitor interacts with five of the nine constituent subunits of F1-ATPase (5). The structure of the bound inhibitor protein is dominated by an α-helix from residues 21–50, referred to as the long α-helix, and in the inhibited complex this α-helix occupies a deep groove at one of the three catalytic interfaces of F1-ATPase, namely the one between the αDP- and βDP-subunits. This groove is lined with residues from α-helices and loops in the C-terminal domains of the αDP- and βDP-subunits. Residues 1–13 of the inhibitor lie within the aqueous cavity surrounding an α-helical coiled-coil in the γ-subunit in the rotor of the enzyme. Residues 1–7 are unresolved, and residues 8–13 form an extended structure with residue 8 interacting with the αTP-subunit. This extended structure is followed by a single turn of an α-helix from residues 14–18, which interacts with the coiled-coil in the γ-subunit, and residues 19 and 20 link this α-helical turn to the long α-helix of IF1. The C-terminal end of this long α-helix extends a short distance beyond the external surface of the α3β3-domain of the enzyme, and beyond residue 50 the monomeric protein is disordered. The majority of the energy for binding the inhibitor to the enzyme is derived from hydrophobic interactions between specific residues in the long α-helix of IF1, and other specific residues mostly in the βDP-subunit of F1-ATPase, augmented by a salt bridge between the inhibitor residue E30 and R408 of the βDP-subunit and a polar interaction between inhibitor residue Q41 and D450 in the βDP-subunit (5). Rather surprisingly, a number of highly conserved charged residues in the long α-helix of the inhibitor, which are essential for inhibitory activity, occupy aqueous spaces in the inhibitory groove and do not interact with the enzyme. It has been postulated that these residues participate at intermediate stages in the pathway of binding that leads to the final inhibited state observed in the crystal structure (6).
How the inhibitor protein reaches this final binding site is the topic of this article. It seems reasonable to suggest that the initial interactions between the inhibitor and the enzyme take place via the most accessible of the three catalytic interfaces, namely the one between the αE- and βE-subunits (5). Then, according to this suggestion, as two ATP molecules are hydrolyzed sequentially, the inhibitor would become entrapped progressively until it had attained the position observed in the structure of the inhibited complex. In the work described here, bovine F1-ATPase was inhibited and crystallized in the presence of a large molar excess of the monomeric inhibitor, resulting in an inhibited complex containing two inhibitor proteins: one bound to the βE-subunit and the second to the βDP-subunit. In a related experiment with a monomeric inhibitor contain the mutation K39A, the inhibited complex contained three inhibitor proteins, one bound to each of the three catalytic interfaces. Taken with other evidence that the inhibitory region of IF1 is intrinsically unfolded (7), these structures support the idea that the initial interactions between the intrinsically disordered inhibitory region of the inhibitor and the enzyme take place via the βE-subunit, and subsequently IF1 folds progressively as the αEβE-catalytic interface converts first to the αTPβTP interface and then to the αDPβDP interface in the process of arresting catalysis.
Results
Structure Determination.
Crystals of inhibited complexes were grown in the presence of MgATP and a 32-fold molar excess of the wild-type inhibitor I1-60His or of the inhibitor containing the mutation K39A. The structures of the two inhibited complexes, known as F1(I1-60His)2 and F1(I1-60His-K39A)3, were determined by molecular replacement with data to 3.3-Å and 3.2-Å resolution, respectively. The asymmetric units of the crystals contain one F1-ATPase with two or three inhibitor proteins bound to the enzyme. The data processing and refinement statistics are summarized in Table 1. The final model of F1(I1-60His)2 (Fig. 1 A and C) contains the following residues of F1-ATPase: αE, 24–406 and 409–510; αTP, 16–402 and 413–510; αDP, 23–402 and 412–510; βE, 9–478; βTP, 9–474; βDP, 9–477; γ, 1–49, 71–96, 109–150, 162–173, and 206–272. Likewise the final model of F1(I1-60His-K39A)3 (Fig. 1 B and D) contains αE, 24–510; αTP, 16–401 and 411–510; αDP, 23–404 and 415–510; βE, 8–477; βTP, 9–477; βDP, 9–477; γ, 1–41, 73–91, 108–153, 164–173, and 205–272. In F1(I1-60His)2 the two inhibitor proteins are bound at the αEβE- and αDPβDP-catalytic interfaces of F1-ATPase, each in association with the C-terminal α-helical domains of the β-subunits. F1(I1-60His-K39A)3 contains an inhibitor protein bound to the C-terminal domains of the β-subunits in all three catalytic interfaces (Fig. 2).
Data collection and refinement statistics for the structures of F1(I1-60His)2 and F1(I1-60His K39A)3
The structure of the F1-(I1-60His)2 and F1-(I1-60His-K39A)3 complexes. The α-, β-, and γ-subunits are red, yellow, and dark blue, the nucleotides are black, and the inhibitor proteins I1-60E, I1-60TP, and I1-60DP are purple, pink, and light blue, respectively. (A and B) Side view of the F1-(I1-60His)2 and F1-(I1-60His-K39A)3 complexes, respectively; (C and D) cross-sectional view in the C-terminal domains of the α- and β-subunits looking along the axis of the coiled-coil region in the γ-subunit away from the membrane domain of the intact F1Fo-ATPase, showing the three α- and the three β-subunits arranged in alternation around the γ-subunit, with C an inhibitor protein bound at two of the three catalytic interfaces of the F1-(I1-60His)2, and D at all three catalytic interfaces of F1-(I1-60His-K39A)3.
Cross-sectional side views of the central stalk and the βE-, βTP-, and βDP-subunits of the F1-(I1-60His-K39A)3 complex. (A–C) Resolved regions of I1-60E, I1-60TP, and I1-60DP, respectively, bound to the C-terminal domains of their respective catalytic β-subunits, and in the case of I1-60DP, its interactions with the γ-subunit. The β- and γ-subunits are yellow and dark blue, the nucleotides are black, and the inhibitor proteins I1-60E, I1-60TP, and I1-60DP are purple, pink, and light blue, respectively.
The extent of the secondary structure of the inhibitor proteins resolved at each catalytic interface differs. In both complexes the least extensively defined inhibitor is the one at the αEβE-catalytic interface. In F1(I1-60His-K39A)3 a more extensive section of the inhibitor protein was resolved at the αTPβTP-catalytic interface. Finally, in both complexes the inhibitor at the αDPβDP-catalytic interface had the most extensive secondary structure. Hereafter, the inhibitors bound at the αEβE, αTPβTP, and αDPβDP-catalytic interfaces are referred to as I1-60E, I1-60TP, and I1-60DP, respectively, and I1-60DP is referred to as the “maximally folded state.” In both structures the nucleotide binding sites in the βDP- and βTP-subunits contained Mg-ADP, but there was no nucleotide associated with the βE-subunits, and the nucleotide binding sites in each of the three noncatalytic α-subunits contained an ATP molecule plus a magnesium ion.
The Binding of I1-60E.
The secondary structures of I1-60E in both complexes are very similar (rmsd for Cα atoms, 0.62 Å; Fig. S1A). Residues 32–49 of the long α-helix of IF1 were resolved in F1(I1-60His)2 and residues 31–49 in F1(I1-60His-K39A)3. There was no electron density corresponding to residues 1–31 in F1(I1-60His)2 and 1–30 in F1(I1-60His-K39A)3, or beyond residue 49 in both complexes. In F1(I1-60His-K39A)3, all of the side chains in the resolved region of I1-60E are discernible, and three of them are involved in specific polar interactions with residues in the C-terminal domain of the βE-subunit of F1-ATPase (Fig. 3A): E31 forms a hydrogen bond with the guanidinium moiety of βE-R408, the hydroxyl of Y33 interacts with βE-K401, and Q41 interacts with βE-D450. Only this last interaction had been observed previously in F1-I1-60His (5). In the structured region of I1-60E, four hydrophobic residues, Y33, F34, L42, and L45, contribute buried surface areas of 70, 65, 89, and 72 Å2, respectively, and the interacting residues in the βE-subunit contribute an additional buried surface area of 296 Å2. In contrast, in F1-I1-60His, where no inhibitor is bound to the βE-subunit, the buried surface area of the same residues is 120 Å2. In F1(I1-60His)2 electron density for the side chains of the resolved residues of I1-60E was not extensive, and so no estimate of buried surface areas was made.
The structures of I1-60E, I1-60TP, I1-60DP and their interactions with subunits of F1-ATPase in the F1-(I1-60His-K39A)3 complex. (A–C) Respectively, side chains of the resolved regions of I1-60E, I1-60TP, and I1-60DP interacting with amino acid residues in the C-terminal domains of the βE-, βTP-, and βDP- subunits, plus E454, which does not interact directly with IF1, but its backbone helps to form the hydrophobic pocket surrounding F34. The depicted regions of I1-60E, I1-60TP, and I1-60DP (residues 31–49, 23–50, and 18–50, respectively) are light blue, and the interacting residues in the βE-, βTP-, and βDP-subunits, the γ-subunit in B, and the αDP-subunit in C are yellow, dark blue, and red, respectively.
The Binding of I1-60TP.
In F1(I1-60His-K39A)3 there was no electron density for residues 1–22 of I1-60TP, but the resolved region now extends from residues 23–50 in the long α-helix, and the number of interactions with F1-ATPase has increased relative to I1-60E. The interactions noted above involving residues Y33 and Q41 of I1-60E and residues K401 and D450, respectively, of the βE-subunit, persisted in the I1-60TP-βTP interface, and there were a number of additional interactions. Inhibitor residue E30 makes a salt bridge with R408 of the βTP-subunit, and F34 occupies a hydrophobic pocket involving residues V404, S405, R408, and E454 of the βTP-subunit. In F1-I1-60His these additional interactions also participate in binding I1-60His to the βDP-subunit (5), and they contribute significantly to the binding energy of IF1 (6). Another additional interaction relative to I1-60E involves R25 of I1-60TP, which forms a salt bridge with E241 of the γ-subunit, and an intermolecular salt bridge between residues R37 and E40 of I1-60TP helps to stabilize the inhibitor. As in I1-60E, residues 51–60 of I1-60TP were not resolved, and similar to I1-60E, the structured domain of I1-60TP contains four hydrophobic residues, Y33, F34, L42, and L45. Their total buried surface area is 351 Å2, 55 Å2 greater than that of the same residues in I1-60E because of the closer interactions between F34 of I1-60TP and the surrounding residues of F1-ATPase.
The Binding of I1-60DP.
The secondary structures of residues 11–50 of I1-60DP are very similar in F1(I1-60His)2 and F1(I1-60His-K39A)3 (Fig. S1B; rmsd for Cα atoms, 0.27 Å). Residues 1–10 are disordered, 11–13 form an extended structure, 14–18 are folded into a single α-helical turn, linked by residues 19 and 20 to the long α-helix, which extends from residues 21–50. Beyond residue 51 in F1(I1-60His)2 and residue 50 in F1(I1-60His-K39A)3 are disordered. The only slight difference between I1-60DP in the F1(I1-60His)2 and F1(I1-60His-K39A)3 complexes and the inhibitor in F1-I1-60His is that the long α-helix in the former F1-inhibitor complexes is bent slightly at its C-terminal end (Fig. S1C). However, the interactions of I1-60DP with F1-ATPase in both F1(I1-60His)2 and F1(I1-60His-K39A)3 are very similar to those observed in F1-I1-60His, with I1-60DP binding to five of the nine subunits of the F1-ATPase. These interactions and those of I1-60E and I1-60TP with F1-ATPase are summarized in Table S1. In both F1(I1-60His)2 and F1(I1-60His-K39A)3, I1-60DP has six ordered hydrophobic residues, V15, F22, Y33, F34, L42, and L45. They contribute a total buried surface area of 543 Å2, greater by 192 and 247 Å2 than for I1-60TP and I1-60E, respectively. These increases arise from an enhanced interaction between L42 and L45 in I1-60DP with the βDP-subunit, and the closure of the αDPβDP-catalytic interface, which allows interactions to form between V15 and F22 of I1-60DP with the γ-subunit and with the neighboring closed βTP-subunit, respectively. In the more open αEβE- and αTPβTP-catalytic interfaces, these interactions with the bound inhibitor proteins cannot form, and V15 and F22 are disordered.
Discussion
Intrinsic Disorder in the Structure of IF1.
Bovine IF1 is a homodimer in which the C-terminal regions from residues 44–84 form an antiparallel α-helical coiled-coil (4, 7). In this dimeric state the N-terminal inhibitory regions extend in approximately opposite directions, allowing the dimer to bind to two F1-ATPase complexes simultaneously in vitro (8). However, there is no convincing evidence that an equivalent structure forms in the membrane-bound F1Fo-ATPase, which is dimerized by an independent mechanism involving protein–protein interactions between specific subunits in the Fo membrane sector of the enzyme (9). In crystals of the dimeric IF1 (4), where the inhibitors form fibers involving extensive intradimer interactions, the α-helical C-terminal region extends in an N-terminal direction as a continuous α-helix into the inhibitory region, so that the structure of each IF1 molecule consists of a single α-helix from residues 18–80, and in solution a fragment consisting of residues 44–84 forms a dimeric antiparallel α-helical coiled-coil. However, NMR spectra of a fragment of bovine IF1 consisting of residues 10–48 contain sharp resonances at or near random coil chemical shifts, showing that this fragment is largely or completely unstructured in solution (7). In contrast, in the structure of the complex of bovine F1-ATPase inhibited by a monomeric version of IF1 consisting of residues 1–60, residues 8–50 are resolved with residues 21–50 forming a single α-helix (5). These observations indicate that the inhibitory region of free bovine IF1 is intrinsically disordered and that it becomes folded either by binding to F1-ATPase or by self-association into the fibers as observed in crystals of the inhibitor (4). The resistance to heat denaturation of bovine IF1 (1), the presence in residues 1–50 of a high number of charged residues (five lysines, five arginines, seven glutamates, and two aspartates), and the scarcity of bulky amino acids (two each of leucines, valines, and phenylalanines, one tyrosine, and no isoleucines or tryptophans) are characteristic features of intrinsically unfolded proteins (10). Moreover, programs that predict the presence of disorder in proteins support the presence of an intrinsically disordered N-terminal region of bovine IF1. Disorder is predicted in residues 1–45 by FoldIndex (11), and in all but residues 12–17 by PONDR (12), and disorder or a loop conformation with high flexibility in residues 1–30 is predicted by DisEMBL (13). Thus, it seems that the N-terminal inhibitory region of bovine IF1 is intrinsically disordered in free solution and that only the C-terminal region from around residue 44 to approximately residue 84 has a secondary structure in the form of an α-helix.
Initial Interaction of Bovine IF1 to F1-ATPase.
The structures of F1(I1-60His)2 and F1(I1-60His-K39A)3 can be interpreted as providing insights into changes in the secondary structure of the inhibitory region of bovine IF1 that occur when the inhibitor binds to F1-ATPase, and this interpretation allows a model of the pathway of binding and folding of the inhibitory region to be constructed. This pathway leads from the unstructured N-terminal inhibitory region of free IF1, which is also present in monomeric I1-60His, to the largely folded structure observed previously in F1-I1-60His, and also of I1-60DP in both F1(I1-60His)2 and F1(I1-60His-K39A)3. In Fig. 4 the binding of IF1 to F1-ATPase is depicted as a four-state process whereby the disordered protein passes through two intermediate states (as observed in the I1-60E and I1-60TP inhibitors) before reaching the final folded state observed in I1-60DP. This process is accompanied by an increase in enthalpy from the formation of interactions between residues in IF1 and other residues in F1-ATPase (Fig. 4A) and an increase in entropy from the burial of hydrophobic residues as IF1 passes via two intermediates from the unbound unfolded state to the final inhibited state (Fig. 4B) (14).
The folding of the intrinsically disordered IF1 upon interaction with F1-ATPase. In solution, the inhibitor is disordered and becomes progressively folded after initial interaction at the αEβE-catalytic interface (E) of F1-ATPase, and subsequently the catalytic interface changing to a αTPβTP interface (TP) and finally a αDPβDP interface (DP). (A) The inhibitor residues that are involved in charged interactions with F1-ATPase. These interactions increase during the binding of the inhibitor leading to an increase in enthalpy that facilitates folding of the IF1. (B) The inhibitor residues that are in hydrophobic interactions with F1-ATPase. These interactions increase during the binding of the inhibitor, leading to an increase in entropy of water molecules that were surrounding the unfolded inhibitor. Residues colored yellow, blue, or orange interact with the neighboring β-subunit, γ-subunit, or the closest nonneighboring β-subunit, respectively.
According to this interpretation, the unfolded inhibitory region enters the enzyme at the αEβE-catalytic interface of F1-ATPase, the most open of the three catalytic interfaces, which provides an accessible surface in the βE-subunit where the unfolded inhibitory region of IF1 can make its initial contacts. This initial mode of interaction has been proposed previously (5), and the present structures strongly favor it over an alternative proposal that the inhibitor enters the enzyme via the partially closed αTPβTP-catalytic interface (15). The interactions that form at this initial stage help to stabilize a 19-residue α-helical segment from residue 31–49 (Fig. 3A).
Completion of the folding of IF1 cannot take place at this initial phase of binding because a number of key interactions required to stabilize the maximally folded state are unable to form. For example, residue E30 of I1-60E cannot make a salt bridge with R408 of the βE-subunit, which can form in both I1-60TP and I1-60DP. Superimposition of maximally folded IF1 on the partially folded I1-60E in the αEβE-catalytic interface demonstrated that inhibitor residue E30 and βE-R408 were 4 Å apart, and that βE-R408 and βE-E454 formed a salt bridge, and βE-R408 clashed with IF1-E31. The importance of E30 in IF1 is demonstrated by the mutation E30A, which abolishes the binding of IF1 to F1-ATPase (6). It was also apparent from this docking experiment that IF1 residues V15 and F22 cannot interact with the γ- and βE-subunits, respectively, at the initial stage of inhibitor binding. In contrast, in the maximally folded IF1 bound to the αDPβDP-catalytic interface, these residues are positioned appropriately to allow the interactions to form and stabilize the structure of the N-terminal region of IF1.
Progression of Binding of Bovine IF1 to F1-ATPase.
After the initial binding of IF1 at the αEβE-catalytic interface, in the next stages of the inhibitory process the γ-subunit rotates through two 120° steps in an anticlockwise direction (as viewed from the membrane domain of intact F1Fo-ATPase), using energy released by the hydrolysis of two ATP molecules at the αDPβDP-catalytic interface. In this way the enzyme becomes inhibited by IF1 bound ultimately at the αDPβDP-catalytic interface.
In the conversion of the αEβE-catalytic interface to a αTPβTP-catalytic interface, the extent of the α-helical inhibitory region of IF1 increases toward its N terminus by residues 23–30 becoming folded, so that now the α-helical segment of IF1 extends from residues 23–49, with residues 1–21 remaining evidently disordered and probably accommodated in the central aqueous cavity of F1-ATPase. In this step, the number of interactions between IF1 and the enzyme increases (Fig. 3B). The salt bridge between E30 of the inhibitor and R408 of the βTP-subunit (discussed above) has now formed, R25 of IF1 has made a salt bridge with γ-E241, and IF1 residues R37 and E40 interact in an interinhibitor salt bridge. This increase in the extent of folding is accompanied by a rise in buried surface area of hydrophobic residues in IF1 relative to I1-60E bound at the αEβE-catalytic interface. This rise is a consequence of an enhanced interaction between F34 of IF1 and the adjacent residues, V404, R408, S405, and E454, in the βTP-subunit. However, the maximally folded inhibitor cannot be accommodated in the αTPβTP-catalytic interface because residues 21 and 22 of IF1 would clash with the γ-subunit. Thus, the extent of formation of secondary structure of IF1 toward its N-terminal end is restricted by the conformation of the γ-subunit in the αTPβTP interface.
In the conversion of the αTPβTP- to the αDPβDP-catalytic interface, the α-helical region of IF1 increases further in an N-terminal direction, so that now it extends from residues 21–50. In comparison with the inhibitor bound at the αTPβTP-catalytic interface, there are now fewer charged interactions between inhibitor and enzyme; residues R25 and E31 of IF1 no longer form ionic interactions with the F1-ATPase, and there is no interinhibitor salt bridge between residues R37 and E40. Residues R25, R37, and E40 are all essential for a functional inhibitor, although they are not in contact with the enzyme in the final inhibited complex represented by F1-I1-60His; as such they were classified as “group 2” residues (6). The present structures demonstrate that they play important but transient roles in the formation of an intermediate state in the pathway of inhibition. There is as yet no explanation for the roles of two other group 2 inhibitor residues, Q27 and K39, and presumably they play a role in the formation of some other undefined intermediate in the folding pathway.
The reduction in interactions in the conversion of the αTPβTP- to the αDPβDP-catalytic interface is compensated by a 55% increase in the total buried surface area of hydrophobic inhibitor residues at the αDPβDP-catalytic interface. This increase arises from greater interactions between the enzyme and IF1 residues, L42 and L45 and the βDP-subunit, and the formation of the new interactions between residues V15 and F22 of IF1 with the γ- and βTP-subunits, respectively, which can now form because the γ-subunit and the neighboring βTP-subunit have adopted appropriate conformations. These conformations also allow a structured region to form from residues 11–20 of IF1, including an α-helical turn from residues 15–18. This turn is immediately adjacent to the γ-subunit and prevents further rotation and hydrolysis of ATP.
One characteristic feature of IF1 is that it is a unidirectional inhibitor of ATP hydrolysis without direct effect on ATP synthesis. Once a proton motive force in the appropriate sense is applied to the rotor of the inhibited complex, its direction of rotation will reverse, and bound IF1 will be ejected from its inhibitory site at the αDPβDP-catalytic interface. The pathway of ejection of IF1 is presumed to be the reversal of the inhibitory pathway and would regenerate the active ATP synthesizing enzyme and the unfolded inhibitory region of IF1.
Comparison of folding of IF1 and other proteins.
The folding pathways of barnase and chymotrypsin inhibitor 2 (CI2) describe a progression from the denatured protein to a semistructured intermediate, to a near native transition state lacking a fully packed hydrophobic core, and finally to the fully folded native state (16, 17). A similar pathway has been described for the Engrailed homeodomain (En-HD) of Drosophilia melanogaster, where the structure of the immediate state in the protein folding pathway was determined by solution NMR (18). These pathways and that proposed for the inhibitory domain of IF1 resemble each other insofar as an initial nucleus of secondary structure forms first, and then this nucleus develops into the final fully folded state. The structures of I1-60E and I1-60TP in the F1(I1-60His)2 and F1(I1-60His-K39A)3 complexes could be considered as being equivalent to the semistructured intermediate states in the folding pathways of barnase, CI2, and En-HD. However, the folding of IF1 differs from barnase, CI2, and En-HD in that it is not a spontaneous process and it requires the participation of specific regions of F1-ATPase.
Biological Roles of IF1.
IF1 is a unidirectional inhibitor of ATP hydrolysis that has no direct effect on ATP synthesis by F1Fo-ATPase (2). The primary biological role suggested for IF1 is to act as an emergency protein that intervenes to inhibit ATP hydrolysis by F1Fo-ATPase when the proton motive force collapses, for example during anoxia. Experimental support for this role is that human cells where expression of IF1 has been suppressed have reduced ATP levels relative to untreated cells (19). However, mice in which the gene for IF1 had been disrupted were viable, suggesting that IF1 is required only under restricted conditions (20). One proposed restricted role is that IF1 is a mediator of apoptosis. Apoptosis is initiated by the release from mitochondria of proapoptotic molecules, such as cytochrome c, and release of cytochrome c from mitochondria increases when IF1 expression is suppressed, and is reduced by the overexpression of IF1 (21). Hence, it has been proposed that IF1 influences whether or not a cell enters apoptosis, and in tumor cells where the levels of IF1 are elevated it may be that IF1 plays a role in suppression of cell death (22). One characteristic feature of intrinsically disordered proteins that fits with the multiple possible roles for IF1 is that such proteins have the ability to recognize and interact with more than one partner protein (23, 24). It has been suggested, for example, that in addition to recognizing and binding to F1-ATPase, IF1 may interact with calmodulin (25), but the physiological relevance of such an interaction is unclear, and other possible interacting partners such as those that may mediate the influence of IF1 on apoptosis remain to be identified.
Materials and Methods
Purification of Bovine Inhibitor Proteins and F1-ATPase.
Residues 1–60 of bovine IF1 plus a C-terminal hexa-histidine, with and without the mutation K39A, were expressed in Escherichia coli C41 (DE3) and purified by affinity chromatography (6). Bovine mitochondrial F1-ATPase was purified as described before (26), except that the buffers lacked azide and β-mercaptoethanol. Proteins were analyzed by SDS/PAGE and stained with Coomassie blue dye (Fig. S2). The molecular masses of inhibitors were measured by mass spectrometry.
Crystallization of Inhibited Complexes.
The conditions for crystal growth were based on those for the F1-I1-60His complex (5). Ammonium sulfate precipitated F1-ATPase and freeze-dried inhibitor proteins were resolubilized in a minimum volume of a buffer prepared in D2O containing 100 mM Tris⋅HCl (pH 8.2), 40 mM MgCl2, and 2 mM EDTA. This solution was passed through a Micro Bio-Spin P-6 column (BioRad Laboratories). The protein concentration of the eluate was adjusted to 10 mg.mL−1, and the solution was mixed with a 32-fold molar excess of inhibitor protein plus 1 mM ATP. Enzyme inhibition was complete after 15 min. A neutralized solution of NaCl (300 mM) and spermidine (5 mM) was added. This solution was centrifuged (100,000 × g, 30 min, 23 °C) and then dispensed into crystallization plates (Nunc) containing filtered liquid paraffin (10 mL). To the drops of protein solution (3 μL; 10 mg.mL−1) was added PEG 4000 (3 μL) from 18% to 24% (wt/vol). Crystal growth was complete within 3 wk. Analysis of the crystals by SDS/PAGE confirmed the presence of the subunits of F1-ATPase and the inhibitor proteins. A harvest solution, identical to the buffer in the crystallization drops but containing additional PEG 4000 [1% (wt/vol)] was added to the drops. Crystals were harvested with 100-μm microloops (MiTeGen), plunged into liquid nitrogen, and stored at 100 K.
Data Collection and Processing.
Diffraction data were collected on a Mar/Rayonix 3 × 3 mosaic 225 detector on Beamline ID23-2 (fixed wavelength 0.87 Å; beam 8 × 8 μm) at the European Synchrotron Radiation Facility, Grenoble, France, or on a Dectris Pilatus detector on Beamline PXI at the Swiss Light Source, Villigen, Switzerland. Diffraction images were integrated with MOSFLM (27) and data reduced with AIMLESS (28). The structures of inhibited complexes were solved by molecular replacement with PHASER (29). The starting model was F1-I1-60His (Protein Data Bank code, 2V7Q) lacking IF1 and bound nucleotides. The structures were remodeled manually with COOT (30), and alternate rounds of rebuilding and refinement were carried out with REFMAC5 (31). The stereochemistry of the model was assessed with COOT and MOLPROBITY (32). Images of structures and electron density maps were generated with PYMOL (33). Buried surface areas of hydrophobic amino acids were calculated with PDBePISA (34).
Acknowledgments
We thank the staff at Beamline ID23eh2 at the European Synchrotron Radiation Facility, and Beamline PXI at the Swiss Light Source. This work was funded by the Medical Research Council.
Footnotes
- ↵1To whom correspondence should be addressed. Email: walker{at}mrc-mbu.cam.ac.uk.
Author contributions: J.V.B. and J.E.W. designed research; J.V.B. and M.G.M. performed research; J.V.B., M.G.M., A.G.W.L., and J.E.W. analyzed data; J.V.B., M.G.M., A.G.W.L., and J.E.W. wrote the paper; and J.E.W. supervised the project.
The authors declare no conflict of interest.
Data deposition: The atomic coordinates and structure factors have been deposited in the Protein Data Bank, www.pdb.org (PDB ID codes 4TSF and 4TT3).
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1411560111/-/DCSupplemental.
Freely available online through the PNAS open access option.
References
- ↵
- Pullman ME,
- Monroy GC
- ↵
- Runswick MJ,
- et al.
- ↵
- ↵
- Cabezón E,
- Runswick MJ,
- Leslie AG,
- Walker JE
- ↵
- Gledhill JR,
- Montgomery MG,
- Leslie AG,
- Walker JE
- ↵
- ↵
- ↵
- ↵
- Arnold I,
- Pfeiffer K,
- Neupert W,
- Stuart RA,
- Schägger H
- ↵
- ↵
- Prilusky J,
- et al.
- ↵
- ↵
- ↵
- Fersht A
- ↵
- ↵
- ↵
- ↵
- ↵
- Fujikawa M,
- Imamura H,
- Nakamura J,
- Yoshida M
- ↵
- Nakamura J,
- Fujikawa M,
- Yoshida M
- ↵
- ↵
- Sánchez-Cenizo L,
- et al.
- ↵
- ↵
- Babu MM,
- Kriwacki RW,
- Pappu RV
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- Schrödinger LLC
- ↵
Citation Manager Formats
Article Classifications
- Biological Sciences
- Biochemistry